A proposal of post-operative nomogram for overall survival in patients with renal cell carcinoma and venous tumor thrombus

被引:26
|
作者
Gu, Liangyou [1 ]
Wang, Zihuan [2 ]
Chen, Luyao [1 ]
Ma, Xin [1 ]
Li, Hongzhao [1 ]
Nie, Wenyuan [1 ]
Peng, Cheng [1 ]
Li, Xintao [1 ]
Gao, Yu [1 ]
Zhang, Xu [1 ]
机构
[1] Chinese Peoples Liberat Army Gen Hosp, PLA Med Sch, State Key Lab Kidney Dis, Dept Urol, Beijing, Peoples R China
[2] Beijing Ctr Dis Control & Prevent, Inst Occupat Hlth, Beijing, Peoples R China
关键词
biomarker; nomogram; prognosis; renal cell carcinoma; thrombus; INFERIOR VENA-CAVA; COLLECTING SYSTEM INVASION; CANCER-SPECIFIC SURVIVAL; SINGLE-CENTER EXPERIENCE; SURGICAL-MANAGEMENT; THROMBECTOMY; NEPHRECTOMY; INVOLVEMENT; IMPACT; STRATIFICATION;
D O I
10.1002/jso.24575
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
OBJECTIVETo identify the predictors of overall survival (OS) and create a post-operative prognostic model for patients with renal cell carcinoma (RCC) and venous tumor thrombus (VTT). PATIENTS AND METHODSThe study cohort included patients with RCC and VTT that underwent full surgical resection between 2006 and 2016. Univariate and multivariate analyses were used to determine the prognostic factors of OS. A nomogram was developed and internally calibrated by bootstrap resampling method. RESULTSA total of 185 patients were identified, including patients with thrombus present in the renal vein (109 patients, 58.9%), infrahepatic inferior vena cava (IVC; 68 patients, 36.8%), and suprahepatic IVC (8 patients, 4.3%). After a median follow-up of 30.2 months (interquartile range, 12.1-48.4 months), 63 (34.1%) patients died. Independent prognostic factors for OS included histological subtype, collecting system invasion, metastasis at surgery, De Ritis ratio (AST/ALT), and serum albumin. Independently predictive variables were used to create a nomogram, which achieved a concordance index of 0.75 for OS. CONCLUSIONSFor patients with RCC and VTT, the developed and internally validated post-operative nomogram can be used to select patients who may benefit from aggressive surveillance regimens or adjuvant therapy clinical trials.
引用
收藏
页码:905 / 912
页数:8
相关论文
共 50 条
  • [1] The value of a postoperative nomogram based on the primary tumor score for overall survival of patients with renal cell carcinoma and inferior vena cava tumor thrombus
    Zhang, Rongjin
    Liu, Zhuo
    Zhang, Min
    Li, Nan
    Liu, Chang
    Zhang, Yongyue
    Sun, Yang
    Zhang, Shudong
    Wang, Shumin
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 190e21 - 190e28
  • [2] Venous tumor thrombus consistency: is it a prognostic factor of survival for patients with renal cell carcinoma?
    Jia, Zhuo
    Tang, Lu
    Liu, Kan
    Guo, Aitao
    Huang, Qingbo
    Peng, Cheng
    Ding, Xiaohui
    Zhang, Lifeng
    Liu, Guojun
    Yang, Guoqiang
    Wang, Baojun
    Li, Hongzhao
    Zhang, Xu
    Ma, Xin
    UPDATES IN SURGERY, 2023, 75 (07) : 2033 - 2038
  • [3] Venous tumor thrombus consistency: is it a prognostic factor of survival for patients with renal cell carcinoma?
    Zhuo Jia
    Lu Tang
    Kan Liu
    Aitao Guo
    Qingbo Huang
    Cheng Peng
    Xiaohui Ding
    Lifeng Zhang
    Guojun Liu
    Guoqiang Yang
    Baojun Wang
    Hongzhao Li
    Xu Zhang
    Xin Ma
    Updates in Surgery, 2023, 75 : 2033 - 2038
  • [4] Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus
    Whitson, Jared M.
    Reese, Adam C.
    Meng, Maxwell V.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (02) : 259 - 263
  • [5] The Adverse Survival Implications of Bland Thrombus in Renal Cell Carcinoma With Venous Tumor Thrombus
    Hutchinson, Ryan
    Rew, Charles
    Chen, Gong
    Woldu, Solomon
    Krabbe, Laura-Maria
    Meissner, Matthew
    Sheth, Kunj
    Singla, Nirmish
    Shakir, Nabeel
    Master, Viraj A.
    Karam, Jose A.
    Matin, Surena F.
    Borregales, Leonardo D.
    Wood, Christopher
    Masterson, Timothy
    Thompson, R. Houston
    Boorjian, Stephen A.
    Leibovich, Bradley C.
    Abel, E. Jason
    Bagrodia, Aditya
    Margulis, Vitaly
    UROLOGY, 2018, 115 : 119 - 124
  • [6] Analysis of Clinicopathological Factors Influencing Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
    Zapala, Lukasz
    Sharma, Sumit
    Kunc, Michal
    Zapala, Piotr
    Klacz, Jakub
    Korczynski, Piotr
    Lipowski, Michal
    Pozniak, Michal
    Suchojad, Tomasz
    Drewa, Tomasz
    Matuszewski, Marcin
    Radziszewski, Piotr
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [7] Low Lymphocyte-to-Monocyte Ratio Is the Potential Indicator of Worse Overall Survival in Patients with Renal Cell Carcinoma and Venous Tumor Thrombus
    Zapala, Lukasz
    Kunc, Michal
    Sharma, Sumit
    Biernat, Wojciech
    Radziszewski, Piotr
    DIAGNOSTICS, 2021, 11 (11)
  • [8] CYTOREDUCTIVE NEPHRECTOMY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA AND TUMOR THROMBUS - TRENDS AND EFFECT ON OVERALL SURVIVAL
    Lenis, Andrew
    Burton, Claire
    Faiena, Izak
    Salmasi, Amirali
    Pooli, Aydin
    Johnson, David
    Drakaki, Alexandra
    Gollapudi, Kiran
    Blumberg, Jeremy
    Pantuck, Allan
    Chamie, Karim
    JOURNAL OF UROLOGY, 2018, 199 (04): : E359 - E360
  • [9] Nomograms for Predicting Overall Survival and Cancer-Specific Survival of Patients With Renal Cell Carcinoma and Venous Tumor Thrombus: A Population-Based Study
    Yang, Lin
    Fu, Bin
    FRONTIERS IN SURGERY, 2022, 9
  • [10] GROWTH KINETICS OF VENOUS TUMOR THROMBUS IN PATIENTS WITH RENAL CELL CARCINOMA
    Nimrod, Barashi S.
    Daniel, Friedman
    Nicholas, Pickersgill
    Joel, Vetter
    Tara, Suresh
    Joseph, Ippolito E.
    Zachary, Smith L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S6 - S6